A detailed history of Qsemble Capital Management, LP transactions in Amgen Inc stock. As of the latest transaction made, Qsemble Capital Management, LP holds 6,019 shares of AMGN stock, worth $2.02 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
6,019
Previous 5,041 19.4%
Holding current value
$2.02 Million
Previous $1.45 Billion 17.87%
% of portfolio
0.37%
Previous 0.36%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$268.87 - $324.56 $262,954 - $317,419
978 Added 19.4%
6,019 $1.71 Billion
Q4 2023

Feb 07, 2024

BUY
$255.7 - $288.46 $1.29 Million - $1.45 Million
5,041 New
5,041 $1.45 Billion
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $482,107 - $570,082
2,250 Added 95.74%
4,600 $1.02 Billion
Q1 2023

May 10, 2023

SELL
$225.79 - $275.2 $677,370 - $825,600
-3,000 Reduced 56.07%
2,350 $568 Million
Q4 2022

Feb 09, 2023

BUY
$229.03 - $291.01 $1.23 Million - $1.56 Million
5,350 New
5,350 $1.41 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $179B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Qsemble Capital Management, LP Portfolio

Follow Qsemble Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qsemble Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Qsemble Capital Management, LP with notifications on news.